Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/16/2013CN102151253B Nifedipine osmotic pump type controlled release tablet
10/16/2013CN102138888B Alprostadil lipid nanosphere gel and preparation method thereof
10/16/2013CN102114012B Medicinal composition for treating heart cerebrovascular diseases as well as preparation method and application thereof
10/16/2013CN102085389B Preparation method of injectable bone repair material
10/16/2013CN102026666B Formulation of insulinotropic peptide conjugates
10/16/2013CN101822652B Vinpocetine transdermal patch and preparation method thereof
10/16/2013CN101810862B Tanshinone IIA oral administration polymer micelle composition
10/16/2013CN101300267B Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof
10/15/2013US8558048 Stabilized protein crystals, formulations comprising them and methods of making them
10/15/2013US8557875 Gene transfer agent composition containing polyamidoamine dendron
10/15/2013US8557874 Hemostatic material
10/15/2013US8557871 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
10/15/2013US8557870 Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium
10/15/2013US8557780 Monomethylvaline compounds capable of conjugation to ligands
10/15/2013US8557607 Magnetic nanoparticles
10/15/2013US8557535 Methods for preparation of platelet rich plasma
10/15/2013US8557294 Film coating for tablets and caplets
10/15/2013US8557290 Multifunction nanoconjugates for imaging applications and targeted treatment
10/15/2013US8557286 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
10/15/2013US8557275 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
10/15/2013US8557274 Slowly digesting starch and fermentable fiber
10/15/2013US8557259 Liquid preparation
10/15/2013US8557253 Stabilizing excipient for inactivated whole virus vaccine
10/15/2013US8557251 Non-live trivalent influenza vaccine for one-dose intradermal delivery
10/15/2013US8557248 Methods and compositions for treating malaria
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2598316C Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
10/15/2013CA2594127C Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
10/15/2013CA2568364C Methods for preparing immunogenic conjugates
10/15/2013CA2549720C Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
10/15/2013CA2533926C Methods and compositions for producing antigenic responses
10/15/2013CA2529055C Improved absorption of fat-soluble nutrients
10/15/2013CA2516322C Glycosaminoglycan-dnase combination therapy
10/15/2013CA2463827C Methods and compositions for controlled release of bioactive compounds
10/10/2013WO2013152314A1 A facile method for making non-toxic biomedical compositions comprising hybrid metal-polymer microparticles
10/10/2013WO2013152059A1 Multicolored ph-activatable fluorescence nanoplatform
10/10/2013WO2013151774A1 Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
10/10/2013WO2013151771A1 Immunostimulatory compositions and methods of use thereof
10/10/2013WO2013151754A1 Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer
10/10/2013WO2013151682A1 Process for forming microbubbles with high oxygen content and uses thereof
10/10/2013WO2013151650A1 Neurophilic nanoparticles
10/10/2013WO2013151326A1 Method of preparing composition for delivering an anionic drug
10/10/2013WO2013150532A1 Lipopeptide conjugates comprising sphingolipid and hiv gp41 derived peptides
10/10/2013WO2013150338A1 Stapled cell penetrating peptides for intracellular delivery of molecules
10/10/2013WO2013150193A1 Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
10/10/2013WO2013150055A1 Solid oral pharmaceutical compositions for isoxazoline compounds
10/10/2013WO2013150052A1 Soft chewable pharmaceutical products
10/10/2013WO2013149981A1 Pharmaceutical composition with improved bioavailability, safety and tolerability
10/10/2013WO2013149974A1 Peptide vaccines for the prevention of foot-and-mouth disease
10/10/2013WO2013149538A1 Pharmaceutical composition
10/10/2013WO2013103424A9 Silk-based multifunctional biomedical platform
10/10/2013WO2013100881A3 Combined pharmaceutical formulation containing diacerein
10/10/2013WO2013095319A3 Formulations of flurbiprofen and diacerein
10/10/2013WO2013095317A3 Pharmaceutical formulations of flurbiprofen and glucosamin
10/10/2013WO2013090842A3 Ophthalmic compositions comprising polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol graft copolymers (soluplus)
10/10/2013WO2013080225A3 Novel parenteral controlled release formulations of nsaid's
10/10/2013WO2012091523A8 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
10/10/2013US20130267610 Novel lipid dipeptide and gel
10/10/2013US20130267609 Novel lipid dipeptide and gel
10/10/2013US20130267597 Polyunsaturated fatty acid-containing solid fat compositions and uses and production thereof
10/10/2013US20130267595 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/10/2013US20130267592 Derivatives of 1-(2-halo-biphenyl-4-yl)-alkanecarboxylic acids for the treatment of neurodegenerative diseases
10/10/2013US20130267587 Pharmaceutical topical composition of mupirocin
10/10/2013US20130267585 Pharmaceutical composition having a cationic excipient
10/10/2013US20130267581 Agent for treating myelofibrosis
10/10/2013US20130267562 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
10/10/2013US20130267553 Liquid pharmaceutical formulations of palonosetron
10/10/2013US20130267547 Prodrugs utilizing a transporter-directed uptake mechanism
10/10/2013US20130267505 Pharmaceutical compositions comprising benzyl alcohol
10/10/2013US20130267504 Pharmaceutical compositions comprising fatty glycerol esters
10/10/2013US20130267503 Pharmaceutical compositions comprising fatty acid esters
10/10/2013US20130267489 Fulvestrant formulations
10/10/2013US20130267486 Polymeric topical compositions
10/10/2013US20130267472 Aqueous ophthalmic solution based on cyclosporin
10/10/2013US20130267471 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
10/10/2013US20130267462 Lipid Construct for Delivery of Insulin to a Mammal
10/10/2013US20130267455 Crosslinked peptide hydrogels
10/10/2013US20130267024 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
10/10/2013US20130266664 Facile method for crosslinking and incorporating bioactive molecules into electrospun fiber scaffolds
10/10/2013US20130266663 Sox9 inhibitors
10/10/2013US20130266661 Amphiphilic cyclic phosphazene trimer, pharmaceutical formulation of hydrophobic drugs by micelle-encapsulation using the amphiphilic cyclic phosphazene trimer, and preparation methods thereof
10/10/2013US20130266659 Methods of treating bladder cancer
10/10/2013US20130266652 Liquid pharmaceutical composition for the delivery of active ingredients
10/10/2013US20130266641 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
10/10/2013US20130266637 Composition for treating cancer by the controlled release of an active substance
10/10/2013US20130266634 Bioactive fus1 peptides and nanoparticle-polypeptide complexes
10/10/2013US20130266632 Drug delivery system based on polyethylene vinylacetate copolymers
10/10/2013US20130266630 Composition for intraocular implantation of bevacizumab
10/10/2013US20130266617 Polymeric micelles for polynucleotide encapsulation
10/10/2013US20130266599 Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
10/10/2013US20130266596 Novel benzodiazepine derivatives
10/10/2013US20130266595 Pyrrolobenzodiazepines and conjugates thereof
10/10/2013US20130266553 Albumin Fusion Proteins
10/10/2013US20130266518 Methods and Compositions for Using Bleomycin-Derivatized Microbubbles
10/10/2013US20130266508 Thermosensitive hydrogel for coating radioisotope and chemotherapeutic agent to treat cancer and method for preparing the same
10/10/2013CA2834083A1 Methods of treatment with arginine deiminase
10/09/2013EP2647648A1 Hydroxyalkyl cellulose
10/09/2013EP2647390A1 Peptide vaccines for the prevention of foot-and-mouth disease
10/09/2013EP2647381A1 Orally disintegrating tablet
10/09/2013EP2646510A1 Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 1712